Skip to content Skip to navigation

20 / 20 Blog Archive

Apr 5 2018 | Posted In: 20/20 Blog
Traumatic brain injury (TBI) is a leading cause of death and disability in the United States, with no currently available therapeutic interventions. We recently characterized histological changes in the eye using two different mouse models of TBI, a fluid percussion injury model and a blast injury...
Apr 2 2018 | Giannini Foundation | Posted In: 20/20 Blog
  Dr. Vinit Mahajan was a panelist at The Giannini Bank of America Foundation Colloquium held at Stanford in April. As a 2003 Giannini Postdoctoral Fellowship Award winner, Dr. Mahajan served as a mentor for current fellows as he focused his discussion on how to get publications and win grants. The...
Mar 22 2018 | Posted In: 20/20 Blog
Dr. Vinit Mahajan spoke on Personalized Proteomics in Eye Disease at Stanford’s annual "In Your Court" gathering of community physicians held at the NBA Warrior’s Oracle Arena. Physician networking was the highlight, but an added bonus was touring the Warriors’ locker room and playing on the same...
Mar 16 2018 | Posted In: 20/20 Blog
Novel CAPN5 mutation associated with inflammatory vitreoretinopathy, hearing loss, and developmental delay.
Feb 21 2018 | MD Magazine | Posted In: 20/20 Blog, Press
Understanding the distinct features of the fovea, macula, and periphery is crucial in the development of effective targeted treatment therapies for various conditions, including age-related macular degeneration (AMD), cystoid macular edema, retinitis pigmentosa, and diabetic retinopathy.